A population sample of 924 African Caribbean adults from Tobago underwent clinical assessment and transthoracic echocardiography, the investigators reported. The cohort ranged in age from 41 to 83 years and had a mean age of 61.7 years; women made up 61.4% of participants. Clinical comorbidity was common: 47.8% of the cohort met criteria for obesity and 20.2% had diabetes. Average systolic blood pressure was reported at approximately 140 mmHg, and 76.7% of participants had hypertension. The study team obtained and analyzed standard echocardiographic measures including left ventricular mass index, left atrial volume index, E/e′ ratio, E/A ratio, diastolic dysfunction classification, left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS).
Short, direct facts are clear. Hypertension and obesity were highly prevalent. Those risk factors framed the structural and functional cardiac findings presented below.
Abnormal left ventricular geometry was common in this cohort: investigators reported it in 77.1% of participants. Concentric remodeling dominated the abnormal patterns, accounting for 69.5% of cases with abnormal geometry. The study team quantified LV hypertrophy and concentric changes across the cohort, and found structural remodeling to be a pervasive feature even though severely reduced systolic function was rare.
Those structural results suggest a population-level burden of remodeling that may reflect long-standing pressure or metabolic stress. The source did not provide detailed hemodynamic or longitudinal exposure data beyond the cross-sectional measures reported.
Echocardiographic diastolic impairment was present but not ubiquitous: the prevalence of diastolic dysfunction was 13.4% in the cohort. Measures of systolic function showed low prevalence of overt systolic failure—LVEF <50% occurred in 1.5% of participants. Abnormal myocardial deformation by strain (GLS ≤ -18%) was observed in 5.2% of the sample. The cohort therefore had a pattern of widespread structural remodeling paired with relatively preserved conventional systolic indices in most participants.
E/e′, a surrogate of filling pressures, was higher in specific subgroups (described below). The source did not report the full breakdown of diastolic grade distribution or precise cutoff values used beyond the aggregate prevalence figures listed above; those methodological specifics were not included in the abstract.
Sex differences emerged in functional measures. Women had significantly higher E/e′ ratios than men and a greater prevalence of Stage A and Stage B heart failure (that is, at-risk or structural heart disease without symptoms), investigators noted. Men had a higher prevalence of symptomatic Stage C heart failure. Age stratification showed that participants aged 65–83 years had higher E/e′ ratios, more concentric remodeling, and a greater prevalence of LV hypertrophy compared with those aged 41–57 years.
These subgroup patterns indicate that older age and female sex were associated with diastolic impairment and structural alterations, whereas symptomatic disease clustered more in men in this sample.
This report is a preprint and has not been peer reviewed; the authors explicitly state that the findings should not be used to guide clinical practice at this stage. The abstract provides cross-sectional data only; longitudinal outcomes or incident heart failure events were not reported in the text provided. The source did not include detailed echocardiographic protocol parameters, reader adjudication procedures, or exact diastolic grading criteria in the abstract, so those methodological details remain unspecified here.
Ethical oversight was obtained: the study received Institutional Review Board approvals from the University of Pittsburgh and the Tobago Ministry of Health and Social Services, and the authors declared that participant consent was secured. Funding was declared from the National Institutes of Health. The authors indicated that all study data are available on reasonable request.
Unanswered questions that remain in this report include whether the observed structural remodeling predicts incident clinical heart failure in this population, how antihypertensive treatment or metabolic control modifies these echocardiographic patterns over time, and the full echocardiography protocol and interobserver variability metrics, which were not detailed in the abstract. These specific follow-up analyses and methodological clarifications would be needed before translating this work into public health or clinical recommendations.